只用一本书提高英语听力能力!重温经典名著双语阅读小编推荐:跟着纪录片学英语不背单词和语法,轻松学英语
返回列表 回复 发帖

[report整理] SENEWS-2010-03-29

提高英语听力能力 找对方法很重要!

[Homework]SENEWS-2010-03-29

This is the VOA Special English Development Report. Millions of babies and children could soon be protected against the deadly disease pneumonia. Two leading drug companies have a grade to supply vaccinums against pneumococcus disease to the world's poorest countries at reduced price. Feather and Blankso Smithclan signed the historic and thans market commitment they agreement last week. The global alines for vaccinums and immunizations for a gaby help the negotiate for a deal. The group says the low cost vaccinums could save that as many as seven million lives by the year twenty thirty.

The World Health Organization says pneumonia kills almost two million children each year. This is more than AIDS, malaria, and measles combined. It is the leading cause of death among young children and more than ninety percent of those death happen in the developing world. These are all reasons why Gabby chose the pneumococcu vaccinum for its first advanced market commitment project. The private public partnerships are designed to increase the *ability of low cost vaccinum in poor areas.

Last year the governments of Italy, the United Kingdom, Canada, Russia, and Norway joined with the bill and malingates* foundation. They provided one and a half billion dollars to launch the pneumococcu vaccinum project. Jeffy Rolen did with the Gaby alines*. He says the money helps to persuade drug makers to take part in the project.

The biggest chance you getting my things that you get support poor country, this is no market, people can afford them. And we don't have malaria that senior, because no one in rich country nearly could suffer from malaria. While we did for the pneumococcu vaccinum that we said we will pay one point five million dollars if you developed the right vaccinums and the right volume* that we need and the right price. It was a gamble. Gamble paid off. Blackso* Smithclan* and Feather* have a grade to provide thirty million does of the vaccinums each year for ten years. The first twenty percent of the vaccinums will sell for seven dollars of dose. The remaining eighty percent will cost three dollars and fifty cents perdoes. That is ninety percent last then current prices in the United States. Mr Wallon* says the agreements in a huge achievement for the developing world.

Information which we tend to take it for granted in country like the United States in Western Europe. That a lot of even no in which disease we would been dusted* again. That's not a case in poor countries, destination is a life or death question for poor people. And you can vaccinated a child to prevented disease from happening, it was a lot of more caused infective than it is be treated that disease after words. And that's the VOA Special English Development Report written by Jone Simms. I'm Steve Ember.

This post was generated by put listening repetition system,  Check the original dictation thread!
1

评分次数

  • csufor

on newton_lord

This is the VOA Special English Development Report.

Millions of babies and children could soon be protected against the deadly disease pneumonia. Two leading drug companies have agreed to supply vaccines against pneumococcal disease to the world's poorest countries at a reduced price.  F- and G-Smith Cline signed the historic Advance Market Commitment agreement last week. The Global Alliance for Vaccines and Immunizations, or GAVI, helped negotiate the deal. The group says the low cost vaccines could save as many as seven million lives by the year 2030.

The World Health Organization says pneumonia kills almost two million children each year. This is more than AIDS, malaria and measles combined. It is the leading cause of death among young children, and, more than 90% of those deaths happen in the developing world.These are all reasons why GAVI chose the pneumococcal vaccine for its first advance market commitment project. The private-public partnerships are designed to increase the availability of low cost vaccines in poor areas. Last year, the governments of Italy, the United Kingdom, Canada, Russia and Norway joined with the Bill and Melinda Gates Foundation. They provided 1.5 billion dollars to launch the pneumococcal vaccine project. J is with the GAVI alliance. He says the money helps to persuade drug makers to take part in the project.

"The biggest challenge of getting life saving vaccines to poor countries is that there's no market, people can't afford them. That's why we don't reallyhave a malaria vaccine yet, because no one in rich countries really suffers from malaria. What we did for the pneumococcal vaccine was we said we will pay 1.5 billion dollars if you develop the right vaccines, and the right volumes that we need and at the right price. And it was a gamble."

That gamble paid off, G- and F- have agreed to provide 30 millions doses of the vaccine each year for 10 years. The first 20% of the vaccines will sell for 7 dollar a dose, the remaining 80% will cost 3 dollars and 50 cents per dose, that is 90% less than current prices in the United States. Mr Rollin says the agreement is a huge achievement for the developing world.

"Vaccination which we tend to take for granted  in countries like the United States or in western Europe, in fact a lot of us don't even know which diseases we have been vaccinated against. That is not the case in poor countries, vaccination is a life or death question  for poor  people and if you can vaccinate a child to  prevent  a disease from happening, it is a lot more cost effective than it is to treat that disease afterwards."

And that is the VOA special English development report written by June Simms. I'm Steve Ember.

这是我发的第一篇修改稿啊~~请多指教!!
1

评分次数

  • csufor

立即获取| 免费注册领取外教体验课一节

[Homework]SENEWS-2010-03-29

This is VOA Special English Development Report.
Millions bodies and children could soon be protected against deadly deseace N*. Two leading drug companies had agreed to supply vaccines the againt no more c* diseace to the world's poorest countries at reduced price.F* and G* SC signed the historic advance market commitment agreement last week.The Global Alliance for Vaccines and .. or deal.
The group says the low cost vaccine can save   as many as 7 million lives  by the year 2030.The world Health Organization says the N* kills almost 2 million children each year.This is more than AIDS ,m* and m combined.It is the leading cause of the death among young children.And more than 90% those death happen in the developping world.
...

This post was generated by put listening repetition system,  Check the original dictation thread!
实现无障碍英语沟通
[HW]
This is the VOA Special English Development Report.

Millions of babies and children could soon be protected against the deadly disease pneumonia. Two leading drug companies have agreed to supply vaccines against pneumococcal disease to the world's poorest countries at a reduced price.

F and B signed the historic advance market commitment agreement last week. The global allies for vaccines and immunizations or G helped negotiated the deal.

The group says the low cost vaccines could save as many as seven million lives by the year 2030.

The World Healthcare Organization says pneumonia kills almost two million children each year. This is more than AIDS, malaria and measles combined. It is the leading cause of deaths among young children. And more than ninety percent of those deaths happen in the developing world. These are all reasons why Gaby choose the pneumococcal vaccine for its first advance market commitment project.

The private public partnerships are designed to increase the avalibality of low cost vaccines in poor areas. Last year the governments of Italy, the United Kingdom, Canada, Russia and Norway joined with a bill and Merlinder Gates Fundation. They provided one and a half billion dollars to launch the pneumococcal vaccine project.

Jerfery Roland is with the Gaby allies. He says the money helps to persuade drug makers to take part in the project.  The biggest change is that you getting vaccine support countries there is no market. People can afford them we don't have malaria vaccine, because no one in rich countries really suffer from malaria. While we did for the pneumococcal vaccine was we said. We will pay one point five billion dollars if you develop the right vaccines in the right * that we need and the right price. And it was the gamble.

That gamble payed off. G and F have agreed to provide thirty million dosis of vaccines each year for ten years. The first twenty percent of the vaccines will sell for seven dollars a dosis. The remaining eighty percent will cost three dollars and fifty cents per dosis. That is ninety percent less than current prices in the United States.

Mister Worlen says the agreement is a huge acheivement for the developing world.  Vaccinations which we tend to take for guranted in countries like the United States or in Western Europe that a lot of ... to know which disease we've been vaccinated against. That not a case for poor countries. Vaccination is a life of death question for poor people. You can vaccinate a child to prevent the disease when happening. It is a lot more cost infectives than it is to treat that disease after words.

And that's the VOA Special English Development Report, written by June Simms. I'm Steve Ember.
1

评分次数

  • csufor

To be a better man .
口译专员推荐—>口译训练软件IPTAM口译通

[Homework]SENEWS-2010-03-29

Homework
This is the VOA Special English Development Report.
Millions of babies and children could soon be protected against the deadly disease pneumonia.Two leading drug companies have agreed to supply vaccines against pneumococcal disease to the world's poorest countries at reduced price.Fiser and B* signed a historic advanced market commitment agreement last week.The global alliance for vaccines and immunizations or G* helped negotiate the bill.The group said the low-cost vaccines could save as many as 7 million lives by the year 2030.The World Health Organization says pnuemonia kills almost 2 million children each year.This is more than AIDS,malaria,and measles combined.It is the leading cause of death among young children and more than 90 percent of those deaths happen in the devoloping world.These are all reasons why G* choose the pneumococcal vaccine for its first advanced market commitment project.The private public partnerships are disigning to increase the availablity of low-cost vacccines in poor areas.Last year,the government of Italy,United Kingdom,Canada,Russia and Norway joined with a bill and Malinda Gates Fundation.They provided one and a half billion dollars to launch the pneumococcal vaccine project.G Roland is with the * alliance.He says the money helps to persuade drug makers to take part in the project.The biggest challenge getting nice vaccines support countries for there is no market,people can not afford them,and until now,so we don't have malaria vaccines yet because no one in these countries really suffers from malaria.What we did for the pneumococcal vaccine is what we said.We will pay one point five billion dollars if you developed the right vaccines.And right * is that we need and right price.And it was a gamble.That gambles paid off G* plan and Fiser at grade to provide 30 million dozens of vaccines each year or ten years.The first 20 percent of the vaccines will sell for 7 dollars per dozen.The remaining 80 percent will cost 3 dollars and 50 cents per dozen.That is 90 percent less than current prices in the United States.Mr.Wallen says the agreement is a huge achievement for the developing world.That's a nation  which we tend to take for granted in countries like the United States,the western European.In fact,a lot of people still don't know which diseases will be investigated against.Hm..That's not the case in poor countries.Vaccination is a life or death question for poor people.And if you vacined a child to prevent the disease from happening,it was a lot more cost-effective than it's to treat that disease afterwards.And that's the VOA Special English Development Report written by June Smith.I'm Steve Ember.

This post was generated by put listening repetition system,  Check the original dictation thread!
1

评分次数

  • csufor

This is the VOA special English, development report
Millions of babies and children could soon be protected aganist the deadly disease - Nomonia. Two leading drug companies have agreed to supply vaccine aganist normal caracol disease to the world poorest countries at reduced prise. Fiser and Glacsor Simith Cl signed the historic advanced market committent agreement last week. The global alliance for vaccines and immunization or gavi help negoiate the deel. The group says the low cost vaccines could save as many as 7 million lives by the year 2030.
The world health organization says Nomonia kills almost 2 millions children each year. This is more than AIDS, Molaria and Misers combined. It is the leading cause of dearth among young children and more than 90 percent of those dearth happen in the developing world.

[Homework]SENEWS-2010-03-29

This is VOA Special English Development Report.
Millions of babies and children could soon be protected aginst the deadly pneumonia. Two leading drug companies have agreed to supply the  against disease to the world's poorest countries at a reduced price. and signed

This post was generated by put listening repetition system,  Check the original dictation thread!
实现无障碍英语沟通
Homework
     红的为听不懂的或听错的,括号内为听错的内容
     绿的为拼写错误的,括号内为拼写错的单词
     蓝的为没听出来的和连续漏听的

This is the VOA Special English Development Report.

Millions of babies and children could soon be protected against the deadly disease pneumonia. Two leading drug companies have agreed to supply vaccines against pneumococcal disease to the world's poorest countries at a reduced price.  Pfizer and GlaxoSmithKline signed the historic Advance Market Commitment agreement last week.  The Global Alliance for Vaccines and Immunizations, or GAVI, helped negotiate the deal.  The group says the low cost vaccines could save as many as seven million lives by the year twenty thirty.

The World Health Organization says pneumonia kills almost two million children each year.  This is more than AIDS, malaria and measles combined.  It is the leading cause of death among young children. And more than ninety percent of those deaths happen in the developing world.

These are all reasons why GAVI chose the pneumococcal vaccine for its first Advance Market Commitment project. The private-public partnerships are designed to increase the availability of low cost vaccines in poor areas.

Last year, the governments of Italy, the United Kingdom, Canada, Russia and Norway joined with the Bill and Melinda Gates Foundation.  They provided one and a half billion dollars to launch the pneumococcal vaccine project. Jeffrey Rowland is with the GAVI alliance.  He says the money helps to persuade drug makers to take part in the project.

JEFFREY ROWLAND: "The biggest challenge of getting life saving vaccines to poor countries is that there's no market.  People can't afford them.  That's why we don't really have a malaria vaccine yet, because no one in rich countries really suffers from malaria.  What we did for the pneumococcal vaccine was we said we will pay one point five billion dollars if you develop the right vaccines, and the right volumes that we need and at the right price. And it was a gamble."

That gamble paid off. GlaxoSmithKline and Pfizer have agreed to provide thirty million doses of the vaccine each year for ten years.  The first twenty percent of the vaccines will sell for seven dollars a dose.  The remaining eighty percent will cost three dollars and fifty cents per dose.  That is ninety per cent less than current prices in the United States.

Mister Rowland says the agreement is a huge achievement for the developing world.

JEFFREY ROWLAND: "Vaccination, which we tend to take for granted in countries like the United States or in Western Europe, in fact a lot of us don't even know which diseases we've been vaccinated against.  That's not the case in poor countries.  Vaccination is a life or death question for poor people and if you can vaccinate a child to prevent a disease from happening it is a lot more cost effective than it is to treat that disease afterwards."

And that's the VOA Special English Development Report, written by June Simms. I'm Steve Ember.
普特听力大课堂

[Homework]SENEWS-2010-03-29

This is the VOA Special English Development Report.
Millions of babies and children could soon be protected aganist the deadly disease pneumonia.Two leading drug companies have agreed to supply vaccine aganist pneumococcal disease to the world's poorest countries at a reduced price.Pfizer and Glaxo Smith Kline sign the historic Advance Market Commitment  agreement last week.The Global Alliance for Vaccines and Immunizations,or the GAVI help negotiate the deal.The group says the low cost vaccines could save as many as seven million lives by the year twenty thirty.
The World Health Organization says pneumonia kills almost two million children each year.This is more than AIDS,malaria and measles combined.It is the leading cause of death among young children.And more than ninety percent of those deaths happen in the developing world.
This are all resons why GAVI chose the pneumococcal vaccine for it's first Advance Market Commitment project.The privat-public partnerships are designed to increse the availability of low cost vaccines in poor areas.
Last year,the governments of Italy,the United Kindom,Canada,Russia and Norway joyed with the Bill and Melinda Gates Foundation.They provided one and a half billion dollars to launch the pnewmococcal vaccine project.Jeffrey Rowland is with the GAVI alliance.He says the money helps to persuade drug makers to take part in the project.
The biggest challenge getting life saving vaccine to poor countries is that there is no market.People can't afford them.That's why we don't really  have a malaria vaccine yet.Because on one in rich countries really suffers from Malaria.What we did for the pneumococcal vaccine was we said we will pay one point five billion dollars is you develop the right vaccines and right volumes that we need and at the right price.And it was a gamble.
That gamble paid off,Glaxo Smith Kline and Pfizer have agreed to provide thirty million doses of the vaccine each year for ten years.The first twenty percent of the vaccines will sell for seven dollars a dose.The remaining eighty percent will cost three dollars and fifty cents per dose.That is ninety percent less than current prices in the United States.
Mister Rowland says the agreement is a huge achievement for the developing world.


This post was generated by put listening repetition system,  Check the original dictation thread!
好栏目推荐之美国口语俚语

[Homework]SENEWS-2010-03-29

This is the VOA Special English Development Report.
Millions of babies and children could soon be protected against deadly disease   numonia.Two leading drug company have agreed to  supply vacacine against     disease to the world's poorest country at reduced price.       signed historical advance market commitment agreement last week.The global alliance for vagccine and sdf or sdf help negociate the deal.The group says low cost vaccine save as many as 7 million lives by the year 2030.The World Health Organization says nomomio kills 2 million children each year,this is more than aids sdf and sdf combined.It is the leading cause of death among young children and more than ninty percent of those death happen in the developing world.This are all reasions why gavy choose the numocacal vaccine for its first advance market commitment project.The private public partnership are designed to  increase availability  of low cost vaccine in poor areas.Last year governments of Italy,the United Kingdom,Canada,Russia and Norway joined with a Melingate Foundation.They provided one and half billion dollars to lauch numocacal vaccine project.
Jevy Roland is with the gavy alliance he says money helps to persuade drug makers to take part in the project.The biggest challenge getting   in poor countries is there is no market.People can't afford them.No one in rich countries really suffer from monila.We did for the numocal vaccine.We said we will pay 1.5 billion dollars if you develop the right vaccine and right value that we need and right price.And it was.. it was .. a gamble.
That gamble paid off.XXX  and XXX have agreed to provide 30 million doses each year for 10 years.The first twenty percent of the vaccines will  sale for seven dollars per dose,  the remaining eighty percent were cost three dollars and fifty  cents per dose,that is ninty percent less than  current prices in the United States.
Mr.Wollen says the agreement is a huge achievement for the deveploping country.Vaccination which we tend to take for granted in countries like United Stats or in Western Europe.In fact, all of us don't even know which disease we've been vaccinate against.Umm, that's not the cases in poor countries.  Vaccination is a life or death question for poor people  and if you can vaccinate a child to prevent disease from happening,it's a lot more cost effective than it is for you to treat that disease afterwards.
And that's the VOA Special English Report.
Written by      I am Steave Vamber

This post was generated by put listening repetition system,  Check the original dictation thread!

[Homework]SENEWS-2010-03-29

This is the VOA Special English Development Report.

Millions   of babies and children could soon be protected agaist the deadly  diseases X. Two leading drug companies have a agree to supply vaccines against normal X disease to the world's poorest countries at a reduce price. Phizer and Glaxo Smithclient signed the historic at vans market commitment agreement last week.

The global alliance for vaccines and x or gabe help negotiate the deal. The group says the low cost vaccines could save as many as 7 million lives by the year 2030. The World Health Organizatioin says X kills almost 2 milion children each year.  This is more than AIDS, Malaria and X combined.  It is the leading cause of death among young children. And more than 90% of those deaths happen in the developing world.

These are all reasons why gabe choose the X vaccine for its first advance market commitment project. The private public partnerships are designed to increase the availbility of low cost vaccines in poor areas. Last year, the government said Italy, the United Kindom, Canada,Russia and Norway joined with the Bill and Malinda Gates Fundation. They provided 1.5 billion dollars to launch the no more X vaccine project.

Jeffery Ronald is with the Gabe alliance he says the money helps to persuade drug makers to take part in the project. The biggest challenge getting vaccine support country is there are no market, people canot affort them. as we do not really have Malaria vaccinial  because no one in rich countries really suffer Malaria. Well, we did for the X vaccine is we said we will pay 1.5 million dollars if you develop the right vaccines and right volumn that we need and the right price. And it was a gamble.

That gamble paid off. Glex Smith and Phizer had a agree to provide 30 million X of the vaccines each year for ten years. The first 20 percent of the vaccines will sell for 7 dollars of gels. The remaining eighty percent will cost 3 dollars and 50 cents per gels. That is 90% less than current prices in the United States. Mr Ronald says the agreement is a huge acheivement for the developing world.

Definiation which we tend to take for granted in countries like X. X and X. In fact, a lot of us still do not know which disease we have been definite againest. That's not the case in four countries. X is a life or death questions for all people. If you can X a child to prevent disease from  happening it is a lot more cost effecive than it is to treat the diesase afterwards.

And that's the VOA Special English Development Report, written by June Simms. I am Steve Ember.
                                                   
This post was generated by put listening repetition system,  Check the original dictation thread!

[Homework]SENEWS-2010-03-29

This is the voa special english development report.
Millions badies and children could soon be protected against the deadly disease Domonia.Two leading drog companies have agreed to supply ... against ... Cacal disease to the world's poorest countries at reduced price.Fazer and Black so smith cline sighed the historic advance market commitment agreement last week.
The globe alliance for ... and ... for ..help the negotiate the deal.The group says the low cost ... could save as many as seven million lives by the year 2030.
The world health organization says ... kills almost two million children each year.This is more than AIDS , malaria and ... combined.It is the leading cause of death among young children and more than 90% of those death happen in the developing world. ... all reasons why ... choose the ...... for its first advance market commitment project.The private public partnerships are desigh to increase the availability of low cost ... in poor areas.Last year the govermentsof Italy ,the United Kingdom,Canada,Russia and Norway joined with the bill and ..... .... They provided one and a half billion dollars to launch the .... .... project.
Jeffry Rolen is with the ... allience.He says the money helps to persuade drog makers to take part in the project.
Jeffry RolenThe biggest challenge getting ... in poor countries is not market ,people can afford them. ... we have we don't have malaria ... because no one in rich countries really suffers from the malaria.While we did for ... was we said we will pay one to five billion dollars if you develop the .... and right .that we need and the right price and it was a .....
That .. payed off. ... and ... have agreed to provide 30 million dozens of the ... each year for ten years.The first percent of the ... will sell 7 dollars a ....The remaining 80precent will cost three dollars and 50 cents per ....That is the 90 percent last the current prices in the United States.Mr Rolen says the agreement is a huge cheapment for the developing world.
Rolen:... that we tend to take for granted in countries like United States or in western ... a lot of these they don't know which disease will been ... against.that's no the case for poor countries ... is the life and death question for poor people and you can... the child to provent the disease from happening it is lot more cost effective than it is to treat that disease afterwards.
And that's the voa special english development report written by Joe Sins.I'm Steven Ember.


This post was generated by put listening repetition system,  Check the original dictation thread!
每天半小时 轻松提高英语口语

[Homework]SENEWS-2010-03-29

2010-3-31
[HW]
This is the VOA special English development report. Millions of babies and children could be protected against the deadly disease pneumonia. Two leading drug companies have agreed to supply vaccines against pneumococcal disease to the world’s poorest countries at reduced price. Pfizer and GlaxoSmithKline sign the historic advance market commitment agreement last week. The globe alliance for vaccines and immunizations or GAVI helped negotiate the deal. The group says the low could save as many as 7 million lives by the 2030. The world health organization says pneumonia kills tow almost tow million children each year. This is more AIDS, malaria and measles combined. It is the leading cause of the young children. More than 90 percent deaths happen in the developing world. These are all reasons why GAVI chooses the pneumonia vaccine for its first advance commitment project. The private public partnerships are designing to increase the availability of low cost caccines in poor areas. Last year, the governments of Italy, the United Kingdom, Canada, Russia and Norway joined with the Bill and Melinda Gates Foundation. They provided 1.5 billion dollars to launch the pneumococcal vaccine project. Jeffrey Rowland is with GAVI alliance. He says the money helps to persuade drug makers to take part in the project. The biggest challenge of getting life saving vaccine to poor countries is that there is no market. People can not afford them. That's the why we don't really have malaria vaccine. Because no one in rich countries really surfers from malaria. What we did for pneumococcal vaccine was we said we will pay 1.5 billion dollars, if you develop the right vaccines and right volumes that we need and the right price. And it was a gamble. Those gamble paid off. So GlaxoSmithKline and Pfizer  have agreed to provide 30 million doses of the vaccine each year for ten years. The first 20 percent of the vaccines will sell for 7 dollars a dose. The remaining 80 percent will cost three dollars and 50 cents per dose. That is 90 percent less than currant prices in the Unites States. Mister Rowland says is a huge achievement for the developing world. Vaccination which we tend to take for granted in countries like United States or Western Europe, in fact, a lot of us that even know which diseases will be vaccinated against. That is not the case for countries. Vaccination is a life or death question for poor people. And we can vaccinate a child to prevent disease from happening. It is a lot more cost effective than it is to treat that disease afterwards. That’s the VOA special English development report written by June Simms. I'm Steve Ember.






This post was generated by put listening repetition system,  Check the original dictation thread!

[Homework]SENEWS-2010-03-29

This is the VOA special English Development report.
Millions of babies and children could soon be protected against the deadly disease pneumonia.Two leading drug companies have agreed to supply vaccines against normal pneumococcal disease to the world poorest countries at reduced price.Pfizer and GlaxoSmithKlein signed the historic advance market commitment last week.The Global alliance for vaccines an immunizations or GAVI help negotiate the deal.The group says the low cost vaccines could save as many as 7 million lives by the year 2030.
The World Health Organization says pneumonia kills almost 2 million chilren each year.This is more than AIDS,malaria and measles combined.It is the leading cause of death among young children.And more than 90 percent of those deaths happen in the developing world.
These are all resons why GAVI chose the pneumococcal vaccine for its first advance market commitment project.The private public partnerships are designed to increase the availability of low cost vaccines in poor areas.
Last year the governments of Italy,the United Kindom,Canada,Russia and Norway joined with the Bill and Melinda Gates Foundation.They provided one and a half billion dollars to launch the pneumococcal vaccine project.Jeffrey Rowland is with the GAVI alliance he says the money helps to persuade drug makers to take part in the project.
The biggest challenge getting life saving vaccines to poor countries is that there is no market.People can't afford them.That's why we don't have malaria vaccine yet,because no one in rich countries really suffers from malaria.What we did for the pneumococcal vaccine was we said we would pay 1.5 billion dollars if you develop the right vaccines and right volume that we need and at right price.And it was a gamble.
That gamble paid off. GlaxoSmithKlein and Pfizer have agreeed to provide 30 million doses of vaccines each year for ten years.The first 20 percent of the vaccines will sell for 7 dollars a dose.The remaining 80 percent will cost 3 dollars and 50 cents per dose.That is 90 percent less than cuurent prices in the United States.
Mr RowLand says the agreement is a huge achievement for the developing world.
Vaccination,which we tend to take for granted in countries like the United States or in Western Europe,in fact a lot of us even don't which diseases we've been vaccinated against.That's not the case for poor countries.Vaccination is a life or death question for poor people.And if you can vaccinated a child to prevent a disease from happening.It is a lot more cost effective than it is to treat that disease afterwards.
And that's the VOA special English development reprot written by June Simms,I'm Steve Ember.

This post was generated by put listening repetition system,  Check the original dictation thread!
口译专员推荐—>口译训练软件IPTAM口译通

[Homework]SENEWS-2010-03-29

This is the VOA Special English development report. Millions of babies and children could soon be protected against the deadly disease pneumonia. Two leading drug companies have agreed to supply vaccines against pneumococcal disease to the world's poorest countries at reduced price. Pfizer and Glaxosmithkline signed the historic Advance Market Commitment agreement last week. The Global Alliance for Vaccines and Immunizations or GAVI helped negotiate the deal. The group says the low cost vaccines could save as many as seven million lives by the year 2030. The World Health Organization says pneumonia kills almost two million children each year. This is more than AIDS, malaria and measles combined. It is the leading cause of death among young children. And more than 90% of those deaths happen in the developing world. These are all reasons why GAVI chose the pneumococcal vaccine for its first advance market project. The private-public partnerships are designed to increase the availability of low cost vaccines in poor areas. Last year, the governments of Italy, the United Kingdom, Canada, Russia and Norway jioned with the Bill and Melinda Gates Foundation. They provided one and a half billion dollars to launch the pneumococcal vaccine project. Jeffrey Rowland is with the GAVI alliance. He says the money helps to persuade drug makers to take part in the project. The biggest challenge of getting life saving vaccines to poor countries is that there is no market. People can't afford them. That's why we don't really have a  malaria vaccine yet, because no one in rich countries really suffers from malaria.What we did for the pneumococcal vaccine was we said we would pay one point five billion dollars if you develop the right vaccines and the right vollumes that we need and at the right price, and it was a gamble.  Gamble paid off. Glaxosmithkline and Pfizer have agreed to provide thirty million doses of the vaccine each year for ten years. The first twenty percent of the vaccines will sell for seven dollars a dose. The remaining eighty percent will cost three dollars and fifty cents per dose. That is ninety percent less than current prices in the United States. Mr Rowland says the agreement is a huge achivement for the developing world. Vaccination, which we tend to take for granted in countries like the United States or in Westen Europe, in fact a lot of us even don't know which disease we've been vaccinated against. That's not the case in poor countries. Vaccination is a life or death question for poor people, and if you can vaccinate a child to prevent a disease from happening, it is a lot more cost effective than it is to treat that disease afterwards.
And that's the VOA Special English development report written by June Simms. I am Steeve Vamber.

This post was generated by put listening repetition system,  Check the original dictation thread!
返回列表